Skip to content

Clinical trials

Completed Lupus Erythematosus, Systemic trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Status: Completed Country / region: Canada Clear all

44 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20053
20061
20082
20106
20113
20125
20131
20177
20182
20194
20204
20211
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed44

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline5
Bristol-Myers Squibb3
Human Genome Sciences Inc., a GSK Company3
Amgen2
Eli Lilly and Company2
Human Genome Sciences Inc.2
MedImmune LLC2
Teva Branded Pharmaceutical Products R&D, Inc.2
UCB Pharma2
University Health Network, Toronto2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic44
Autoimmune Diseases8
Lupus Nephritis4
Immune System Diseases3
Connective Tissue Diseases2
Arthritis1
Arthritis, Juvenile1
Arthritis, Rheumatoid1
Colitis, Ulcerative1
Crohn Disease1

Trials

Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.